Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
In this study, the researchers hope to learn about SGLT2 inhibition on EGP (endogenous
glucose production) and plasma glucose concentration in diabetic subjects. Researchers will
examine diabetes and the role of increased plasma glucagon, decline in plasma insulin, and
fall in plasma glucose concentration.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio